Panel session from World Orphan Drug Congress on Real World Evidence

See & hear from:

• Martine Zimmermann, Global Head of Regulatory Affairs, Alexion Pharmaceuticals, Inc.
• Javier Jimenez, EVP RWE & Late Phase, Syneos Health
  
• Matt Eagles, Head of Patient Engagement, Havas Lynx Group
  
• Moderator: Christopher Rudolf, Founder & CEO, Volv Global

Watch the video about how RWE is accelerating development and enabling patients to be part of the rare disease drug development journey...